Suppr超能文献

塞法林通过靶向 NRF2 促进铁死亡发挥抗肺癌功效。

Cephaeline promotes ferroptosis by targeting NRF2 to exert anti-lung cancer efficacy.

机构信息

Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, PR China.

Department of Clinical Medicine, School of Medicine, Hangzhou City University, Hangzhou, PR China.

出版信息

Pharm Biol. 2024 Dec;62(1):195-206. doi: 10.1080/13880209.2024.2309891. Epub 2024 Feb 9.

Abstract

CONTEXT

Cephaeline is a natural product isolated from ipecac ( [Brot.] A. Rich. [Rubiaceae]). It exhibits promising anti-lung cancer activity and ferroptosis induction may be a key mechanism for its anti-lung cancer effect.

OBJECTIVES

This study investigates the anti-lung cancer activity and mechanisms of cephaeline both and .

MATERIALS AND METHODS

H460 and A549 lung cancer cells were used. The cephaeline inhibition rate on lung cancer cells was detected a Cell Counting Kit-8 assay after treatment with cephaeline for 24 h. Subsequently, the concentrations of 25, 50 and 100 nM were used for experiments. In addition, the antitumour effects of cephaeline (5, 10 mg/kg) were evaluated after 12 d of cephaeline treatment.

RESULTS

Cephaeline showed significant inhibitory effects on lung cancer cells, and the IC of cephaeline on H460 and A549 at 24, 48 and 72 h were 88, 58 and 35 nM, respectively, for H460 cells and 89, 65 and 43 nM, respectively, for A549 cells. Meanwhile, we demonstrated that ferroptosis is the key mechanism of cephaeline against lung cancer. Finally, we found that cephaeline induced ferroptosis in lung cancer cells by targeting NRF2.

DISCUSSION AND CONCLUSION

We demonstrated for the first time that cephaeline inhibits NRF2, leading to ferroptosis in lung cancer cells. These findings may contribute to the development of innovative therapeutics for lung cancer.

摘要

背景

颅泻宁是从吐根([Brot.] A. Rich. [Rubiaceae])中分离得到的天然产物。它表现出有希望的抗肺癌活性,铁死亡诱导可能是其抗肺癌作用的关键机制。

目的

本研究探讨颅泻宁对肺癌的抗癌活性及其机制。

材料和方法

使用 H460 和 A549 肺癌细胞。用颅泻宁处理 24 小时后,用细胞计数试剂盒-8 法检测颅泻宁对肺癌细胞的抑制率。随后,使用 25、50 和 100 nM 浓度进行实验。此外,还评估了颅泻宁(5、10 mg/kg)治疗 12 天后的抗肿瘤作用。

结果

颅泻宁对肺癌细胞表现出显著的抑制作用,颅泻宁对 H460 和 A549 的 IC 分别为 24、48 和 72 小时时为 88、58 和 35 nM,H460 细胞为 89、65 和 43 nM,A549 细胞为 43 nM。同时,我们证明铁死亡是颅泻宁抗肺癌的关键机制。最后,我们发现颅泻宁通过靶向 NRF2 诱导肺癌细胞发生铁死亡。

讨论与结论

我们首次证明颅泻宁抑制 NRF2,导致肺癌细胞发生铁死亡。这些发现可能有助于开发治疗肺癌的创新疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cca/10860416/46ea33486f50/IPHB_A_2309891_F0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验